Additionally, Li et al. have demonstrated that approximately 70% of all endometrial tumors exhibit a reduction in m6A methylation levels compared with that of normal endometrial tissues and that the downregulation or mutation of either METTL3 or METTL14 may be responsible for this reduction (6). This evidence concerns the gene METTL14 and endometrium neoplasm.